Context: Detection of the BRAF V600E mutation in fine-needle aspiration cytology (FNAC) specimens may increase the value of FNAC. Objective: The objectives of the study was to compare the diagnostic performance of BRAF assays that differ in sensitivity and to examine the associations between the BRAF V600E mutation status and the clinicopathological features in papillary thyroid carcinoma (PTC). Design and Setting: Three molecular assays were performed in all subjects and compared with regard to FNAC and histology results. Participants: We evaluated 4585 consecutive patients who were found to have malignant or indeterminate thyroid nodules by ultrasonography. Outcome Measures: All FNAC samples were tested for the BRAF V600E mutation using conventional Sanger sequencing, dual-priming oligonucleotide-PCR, and mutant enrichment with 3′-modified oligonucleotide (MEMO) sequencing. Results: The detection sensitivities of the three molecular assays for the BRAF V600E mutation were 20, 2, and 0.1%, respectively. Compared with conventional Sanger sequencing (n = 673), dual-priming oligonucleotide-PCR and MEMO sequencing detected more tumors with the BRAF V600E mutation (n = 919 and n = 1044, respectively), especially tumors with a benign, indeterminate, or nondiagnostic cytology. All BRAF-positive tumors that were histologically examined were shown to be PTC, regardless of cytology results. The clinical sensitivities of the three assays for detecting PTC were 54.8, 74.4, and 79.7%, respectively. BRAF V600E mutations in microcarcinomas (≤10 mm) were detected more efficiently as the detection sensitivity of the assay increased (P < 0.001). Tumor size correlated significantly with multifocality, extrathyroidal extension, and lymph node metastasis (P = 0.003, P < 0.001 and P < 0.001, respectively), but the BRAF V600E mutation status was not associated with any of those features. Conclusion: Highly sensitive and specific molecular assays such as MEMO sequencing are optimal for detecting the BRAF mutations in thyroid FNAC because these techniques can detect PTC that might be missed by cytology or less sensitive molecular assays.
4 May 2020 in IEEE/ASME Transactions on Mechatronics
UDP-glucuronosyltransferase 1A1 (UGT1A1) is the key enzyme for bilirubin conjugation. Defects in this enzyme can cause a nonhemolytic unconjugated hyperbilirubinemia, such as Crigler–Najjar syndrome type 1 (CN1) and 2 (CN2) and Gilbert syndrome (GS). In 1991, the cDNA of the human UGT1A1 gene was cloned, and this led to the identification of genetic defects in patients with CN1, CN2, and GS (1)(2)(3). It was shown that homozygous or compound heterozygous mutations of the UGT1A1 gene can lead to these inheritable unconjugated hyperbilirubinemias, and >30 variants have been identified (4)(5). In GS, a TATAA box variant [A(TA)6TAA>A(TA)7TAA] in the promoter region of the UGT1A1 gene has been reported in Caucasian populations, and several polymorphisms in the coding region, including 211G>A (G71R), have been reported to have similar associations with GS in Japanese populations (6)(7)(8). Recently, Sugatani et al. (9) identified a T-to-G substitution in the phenobarbital-responsive enhancer module 3279 bp upstream from the UGT1A1 gene. They suggested that the −3279T>G polymorphism could be another risk factor for the development of mild hyperbilirubinemia Presumably, different combinations of the polymorphisms (haplotypes) in the UGT1A1 gene associated with GS or mild hyperbilirubinemia might produce a variety of serum total bilirubin (T-Bil) concentrations. Because these polymorphisms in the UGT1A1 gene lie in a relatively small region (Fig. 1A⇓ ), a certain extent of linkage disequilibrium (LD) among these polymorphisms is expected. Therefore, haplotype analysis is more reasonable than association analysis using any single polymorphism to reveal the genetic background of an increased serum T-Bil concentration. We analyzed the haplotype structure of the UGT1A1 gene and investigated its relationship to the serum T-Bil concentration in healthy Korean males. The study participants were 324 healthy Korean males [mean (SD) age, 49.8 …
Stairs are common obstacles in indoor environments and are difficult to overcome for robots. The speed of robot stair-climbing should be similar to that of humans for commercial products, but their speed remains limited. Additionally, the variety of dimensions of stairs is also a significant problem for robust stair-climbing by robots. In this paper, a curved spoke-based tri-wheel mechanism is proposed for fast and robust stair-climbing. The goal speed of stair-climbing is similar to the human speed for variously sized stairs. The proposed wheel system is composed of a tri-wheel mechanism with a curved spoke, wherein the dimensions of the mechanism are determined based on a kinematic analysis. Between the tri-wheels, a stopper mechanism acts to make the initial condition of the sequential stair-climbing the same as the initial starting condition. Static analysis to analyze the minimum friction coefficient is performed to verify the performance of the robot. Experiments based on the prototype are performed to verify the stair-climbing speed for variously sized stairs; the results indicate that fast and robust stair climbing performance is achieved. These findings can be used to design an indoor service robot for various applications.